SEARCH

SEARCH BY CITATION

References

  • 1
    Matarese G. Leptin and the immune system: how nutritional status influences the immune response. Eur Cytokine Netw 2000: 11: 713.
  • 2
    Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998: 395: 76370.
  • 3
    La Cava A, Matarese G. The weight of leptin in immunity. Nat Rev Immunol 2004: 4: 3719.
  • 4
    Ozata M, Ozdemir IC, Licinio J. Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab 1999: 84: 368695.
  • 5
    Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998: 394: 897901.
  • 6
    Howard JK, Lord GM, Matarese G et al. Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest 1999: 104: 10519.
  • 7
    Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006: 6: 77283.
  • 8
    Shen J, Sakaida I, Uchida K, Terai S, Okita K. Leptin enhances TNF-alpha production via p38 and JNK MAPK in LPS-stimulated Kupffer cells. Life Sci 2005: 77: 150215.
  • 9
    Faggioni R, Jones-Carson J, Reed DA et al. Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor alpha and IL-18. Proc Natl Acad Sci U S A 2000: 97: 236772.
  • 10
    Santos-Alvarez J, Goberna R, Sanchez-Margalet V. Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol 1999: 194: 611.
  • 11
    Zarkesh-Esfahani H, Pockley AG, Wu Z, Hellewell PG, Weetman AP, Ross RJ. Leptin indirectly activates human neutrophils via induction of TNF-alpha. J Immunol 2004: 172: 180914.
  • 12
    Zhao Y, Sun R, You L, Gao C, Tian Z. Expression of leptin receptors and response to leptin stimulation of human natural killer cell lines. Biochem Biophys Res Commun 2003: 300: 24752.
  • 13
    Farooqi IS, Matarese G, Lord GM et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 2002: 110: 1093103.
  • 14
    Fujita Y, Murakami M, Ogawa Y et al. Leptin inhibits stress-induced apoptosis of T lymphocytes. Clin Exp Immunol 2002: 128: 216.
  • 15
    De Rosa V, Procaccini C, Cali G et al. A key role of leptin in the control of regulatory T cell proliferation. Immunity 2007: 26: 24155.
  • 16
    Williams KC, Ulvestad E, Hickey WF. Immunology of multiple sclerosis. Clin Neurosci 1994: 2: 22945.
  • 17
    Matarese G, Di Giacomo A, Sanna V et al. Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J Immunol 2001: 166: 590916.
  • 18
    Sanna V, Di Giacomo A, La Cava A et al. Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses. J Clin Invest 2003: 111: 24150.
  • 19
    Matarese G, Carrieri PB, La Cava A et al. Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells. Proc Natl Acad Sci U S A 2005: 102: 51505.
  • 20
    Lock C, Hermans G, Pedotti R et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 2002: 8: 5008.
  • 21
    Batocchi AP, Rotondi M, Caggiula M et al. Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta. J Neuroimmunol 2003: 139: 1504.
  • 22
    Gilliam LK, Jensen RA, Yang P et al. Evaluation of leptin levels in subjects at risk for type 1 diabetes. J Autoimmun 2006: 26: 1337.
  • 23
    Coleman DL. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 1978: 14: 1418.
  • 24
    Togawa K, Moritani M, Yaguchi H et al. Multidimensional genome scans identify the combinations of genetic loci linked to diabetes-related phenotypes in mice. Hum Mol Genet 2006: 15: 11328.
  • 25
    Boillot D, Assan R, Dardenne M et al. T-lymphopenia and T-cell imbalance in diabetic db/db mice. Diabetes 1986: 35: 198203.
  • 26
    Leiter EH, Prochazka M, Shultz LD. Effect of immunodeficiency on diabetogenesis in genetically diabetic (db/db) mice. J Immunol 1987: 138: 32249.
  • 27
    Serreze DV, Leiter EH. Genes and cellular requirements for autoimmune diabetes susceptibility in nonobese diabetic mice. Curr Dir Autoimmun 2001: 4: 3167.
  • 28
    Atkinson MA, Leiter EH. The NOD mouse model of type 1 diabetes: as good as it gets? Nat Med 1999: 5: 6014.
  • 29
    Matarese G, Sanna V, Lechler RI et al. Leptin accelerates autoimmune diabetes in female NOD mice. Diabetes 2002: 51:135661.
  • 30
    Nishimura M, Miyamoto H. Immunopathological influence of the Ay, db, ob and nu genes placed on the inbred NOD background as murine models for human type I diabetes. J Immunogenet 1987: 14:127130.
  • 31
    Lee CH, Reifsnyder PC, Naggert JK et al. Novel leptin receptor mutation in NOD/LtJ mice suppresses type 1 diabetes progression: I. Pathophysiological analysis. Diabetes 2005: 54: 252532.
  • 32
    Lee C-H, Chen Y-G, Reifsnyder PC et al. Novel leptin receptor mutation in NOD/LtJ mice suppresses type 1 diabetes progression. II. Immunologic analysis. Diabetes 2006: 55: 1718.
  • 33
    Litherland SA, Xie TX, Grebe KM et al. Signal transduction activator of transcription 5 (STAT5) dysfunction in autoimmune monocytes and macrophages. J Autoimmun 2005: 24: 297310.
  • 34
    Litherland SA, Xie XT, Hutson AD et al. Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitus. J Clin Invest 1999: 104: 51523.
  • 35
    Hekerman P, Zeidler J, Bamberg-Lemper S et al. Pleiotropy of leptin receptor signalling is defined by distinct roles of the intracellular tyrosines. FEBS J 2005: 272: 10919.
  • 36
    Fruhbeck G. Intracellular signalling pathways activated by leptin. Biochem J 2006: 393: 720.
  • 37
    Anderson MS, Bluestone JA. The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 2005: 23: 44785.
  • 38
    Chen YG, Choisy-Rossi CM, Holl TM et al. Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes. J Immunol 2005: 174: 1196204.
  • 39
    Busso N, So A, Chobaz-Peclat V et al. Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J Immunol 2002: 168: 87582.
  • 40
    Bernotiene E, Palmer G, Talabot-Ayer D et al. Delayed resolution of acute inflammation during zymosan-induced arthritis in leptin-deficient mice. Arthritis Res Ther 2004: 6: R25663.
  • 41
    Fraser DA, Thoen J, Reseland JE, Forre O, Kjeldsen-Kragh J. Decreased CD4+ lymphocyte activation and increased interleukin-4 production in peripheral blood of rheumatoid arthritis patients after acute starvation. Clin Rheumatol 1999: 18: 394401.
  • 42
    Fraser DA, Thoen J, Bondhus S et al. Reduction in serum leptin and IGF-1 but preserved T-lymphocyte numbers and activation after a ketogenic diet in rheumatoid arthritis patients. Clin Exp Rheumatol 2000: 18: 20914.
  • 43
    Bokarewa M, Bokarew D, Hultgren O, Tarkowski A. Leptin consumption in the inflamed joints of patients with rheumatoid arthritis. Ann Rheum Dis 2003: 62: 9526.
  • 44
    Hultgren OH, Tarkowski A. Leptin in septic arthritis: decreased levels during infection and amelioration of disease activity upon its administration. Arthritis Res 2001: 3: 38994.
  • 45
    Popa C, Netea MG, Radstake TR, Van Riel PL, Barrera P, van der Meer JW. Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis. Ann Rheum Dis 2005: 64: 11958.
  • 46
    Palmer G, Gabay C. A role for leptin in rheumatic diseases? Ann Rheum Dis 2003: 62: 9135.
  • 47
    Siegmund B, Lear-Kaul KC, Faggioni R, Fantuzzi G. Leptin deficiency, not obesity, protects mice from Con A-induced hepatitis. Eur J Immunol 2002: 32: 55260.
  • 48
    Tarzi RM, Cook HT, Jackson I, Pusey CD, Lord GM. Leptin-deficient mice are protected from accelerated nephrotoxic nephritis. Am J Pathol 2004: 164: 38590.
  • 49
    Guzik TJ, Mangalat D, Korbut R. Adipocytokines – novel link between inflammation and vascular function? J Physiol Pharmacol 2006: 57: 50528.
  • 50
    Bruining GJ. Association between infant growth before onset of juvenile type-1 diabetes and autoantibodies to IA-2. Netherlands Kolibrie study group of childhood diabetes. Lancet 2000: 356: 6556.